FDA approves recombinant flu vaccine : Was rejected in 2009, arguing that there was insufficient evidence that the vaccine was safe

17 Jan 2013 | 19:49 GMT | Posted by Heidi Ledford | The US Food and Drug Administration (FDA) has approved the first seasonal flu vaccine comprised of recombinant proteins, rather than inactivated or weakened virus. The 16 January approval of Flublok, developed by Protein Sciences Corporation in Meriden, Connecticut, arrives as US emergency rooms…

Seasonal flu vaccination increase the risk of infection with pandemic H1N1 flu by 68%

2010 study posted for filing Contact: Andrew Hyde press@plos.org 44-122-346-3330 Public Library of Science Did seasonal flu vaccination increase the risk of infection with pandemic H1N1 flu? Press release from PLoS Medicine Did seasonal flu vaccination increase the risk of infection with pandemic H1N1 flu? In September 2009, news stories reported that researchers in Canada…

Influenza Vaccine Failure among Highly Vaccinated Military Personal, No protection against Pandemic Strains.

Introduction Following the 2009 influenza A/H1N1 (pH1N1) pandemic, both seasonal and pH1N1 viruses circulated in the US during the 2010–2011 influenza season; influenza vaccine effectiveness (VE) may vary between live attenuated (LAIV) and trivalent inactivated (TIV) vaccines as well as by virus subtype. Materials and Methods Vaccine type and virus subtype-specific VE were determined for…